NASDAQ: PAHC
Phibro Animal Health Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PAHC stock forecasts and price targets.

Forecast return on equity

Is PAHC forecast to generate an efficient return?

Company
41.1%
Industry
-41.17%
Market
162.1%
PAHC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PAHC forecast to generate an efficient return on assets?

Company
11.33%
Industry
21%
PAHC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PAHC earnings per share forecast

What is PAHC's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$3.57+40.42%
Avg 2 year Forecast
$3.95+55.54%
Avg 3 year Forecast
$4.23+66.45%
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PAHC revenue forecast

What is PAHC's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$1.6B+4.67%
Avg 2 year Forecast
$1.7B+8.44%
Avg 3 year Forecast
$1.7B+10.97%
PAHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PAHC earnings growth forecast

How is PAHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
18.71%
Industry
10.53%
Market
32.82%
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PAHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PAHC revenue growth forecast

How is PAHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
3.61%
Industry
6.34%
Market
12.06%
PAHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PAHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PAHC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
PAHC$35.57N/AN/A
AMPH$29.71$22.00-25.95%Hold
ALVO$4.55$8.00+75.82%Strong Buy
ANIP$71.47$98.67+38.05%Buy
HROW$32.16$54.00+67.91%Strong Buy

Phibro Animal Health Stock Forecast FAQ

What is PAHC's earnings growth forecast for 2027-2029?

(NASDAQ: PAHC) Phibro Animal Health's forecast annual earnings growth rate of 18.71% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 10.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.82%.

Phibro Animal Health's earnings in 2026 is $102,713,000.On average, 5 Wall Street analysts forecast PAHC's earnings for 2027 to be $144,809,677, with the lowest PAHC earnings forecast at $138,467,707, and the highest PAHC earnings forecast at $149,637,208. On average, 5 Wall Street analysts forecast PAHC's earnings for 2028 to be $160,408,813, with the lowest PAHC earnings forecast at $149,210,891, and the highest PAHC earnings forecast at $174,789,901.

In 2029, PAHC is forecast to generate $171,659,517 in earnings, with the lowest earnings forecast at $156,770,910 and the highest earnings forecast at $185,447,822.

If you're new to stock investing, here's how to buy Phibro Animal Health stock.

What is PAHC's revenue growth forecast for 2027-2029?

(NASDAQ: PAHC) Phibro Animal Health's forecast annual revenue growth rate of 3.61% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.06%.

Phibro Animal Health's revenue in 2026 is $1,540,974,000.On average, 5 Wall Street analysts forecast PAHC's revenue for 2027 to be $65,490,385,639, with the lowest PAHC revenue forecast at $62,648,273,429, and the highest PAHC revenue forecast at $67,723,473,804. On average, 5 Wall Street analysts forecast PAHC's revenue for 2028 to be $67,845,278,613, with the lowest PAHC revenue forecast at $64,597,150,373, and the highest PAHC revenue forecast at $70,443,781,205.

In 2029, PAHC is forecast to generate $69,428,741,130 in revenue, with the lowest revenue forecast at $66,708,433,729 and the highest revenue forecast at $71,458,821,280.

What is PAHC's forecast return on assets (ROA) for 2027-2029?

(NASDAQ: PAHC) forecast ROA is 11.33%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 21%.

What is PAHC's Earnings Per Share (EPS) forecast for 2027-2029?

(NASDAQ: PAHC) Phibro Animal Health's current Earnings Per Share (EPS) is $2.54. On average, analysts forecast that PAHC's EPS will be $3.57 for 2027, with the lowest EPS forecast at $3.41, and the highest EPS forecast at $3.69. On average, analysts forecast that PAHC's EPS will be $3.95 for 2028, with the lowest EPS forecast at $3.68, and the highest EPS forecast at $4.31. In 2029, PAHC's EPS is forecast to hit $4.23 (min: $3.86, max: $4.57).

What is PAHC's forecast return on equity (ROE) for 2027-2029?

(NASDAQ: PAHC) forecast ROE is 41.1%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.